GALD — Galderma AG Share News
0.000.00%
Last trade - 00:00- CH₣41.81bn
- CH₣43.39bn
- $5.24bn
Swiss stocks - Factors to watch on June 26
Advisory: Alert tagged to multiple companies from a research report withdrawn
Brief: Galderma Receives U.S. FDA Approval For Differin Epiduo Acne Gel Prescription-To-Otc Switch
Bayer down after 'mixed reception' at U.S Supreme Court
Europe Research Roundup: Asta Energy Solutions, Dassault Systemes, Nokia
Swiss stocks - Factors to watch on April 24
Skincare company Galderma posts 25.5% sales leap, driven by US market (updated)
Galderma rises after Q1 sales beat
Skincare firm Galderma posts 25.5% sales jump driven by US market
Brief: Galderma Q1 Net Sales Of $1.473 Billion, Up 25.5%
Swiss stocks - Factors to watch on April 22
Europe Research Roundup: Antofagasta, Danske Bank, Munich Re
Europe Research Roundup: Diageo, Enagas, Suedzucker
Swiss stocks - Factors to watch on March 31
Brief: Galderma - Nemolizumab Data Demonstrate Benefits For Children Moderate-To-Severe Atopic Dermatitis
Citi resumes Galderma with 'buy' on dermatology strategy, Nemluvio upside
Europe Research Roundup: BASF, Galderma, Lanxess
Brief: Galderma Receives U.S. FDA Approval For Restylane Contour For The Correction Of Temple Hollowing
Brief: Galderma Says Board Proposes Dividend Of 0.35 CHF Per Registered Share